Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

SHA:600488 Revenue

Tianjin Tianyao Pharmaceuticals had revenue of 608.11M CNY in the quarter ending March 31, 2026, a decrease of -22.61%. This brings the company's revenue in the last twelve months to 2.73B, down -12.97% year-over-year. In the year 2025, Tianjin Tianyao Pharmaceuticals had annual revenue of 2.91B, down -9.56%.

• Revenue (ttm): 2.73B
• Revenue Growth: -12.97%
• P/S Ratio: 2.90
• Revenue / Employee: 946.73K
• Employees: 2,884
• Market Cap: 7.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.91B	-307.25M	-9.56%
Dec 31, 2024	3.22B	-567.54M	-15.00%
Dec 31, 2023	3.78B	93.90M	2.55%
Dec 31, 2022	3.69B	-59.73M	-1.59%
Dec 31, 2021	3.75B	631.82M	20.27%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error